Back
Mastercard Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
69
MA
Mastercard
Last Price:
529.19
Seasonality Move:
7.03%
Buy
97
RYTM
Rhythm Pharmaceuticals
Last Price:
64.04
Seasonality Move:
9.98%
Buy
69
Mastercard (MA)
is a Buy
Is Mastercard a Buy, Sell or Hold?
- The current Mastercard [MA] share price is $530.12. The Score for MA is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- MA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
97
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $65.58. The Score for RYTM is 97, which is 94% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
MA Stock Price Chart
What is Mastercard's stock price today?
-
The Mastercard share price today is $530.12
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MA is experiencing slight selling pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $65.58
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing selling pressure, which indicates risk of future bearish movement.
MA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.39 | Buy |
Relative Strength Index (14 RSI): | 67.39 | Buy |
Chaikin Money Flow: | -900803 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (500.55 - 518.13) | Buy |
Bollinger Bands (100): | (449.81 - 502.93) | Buy |
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.64 | Buy |
Relative Strength Index (14 RSI): | 75.47 | Buy |
Chaikin Money Flow: | -747845 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.34 - 58.08) | Buy |
Bollinger Bands (100): | (43.86 - 53.38) | Buy |
MA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 514.09 | Buy |
20-day SMA: | 512.25 | Buy |
50-day SMA: | 500.02 | Buy |
200-day SMA: | 468.9 | Buy |
8-day EMA: | 518.09 | Buy |
20-day EMA: | 511.52 | Buy |
50-day EMA: | 499.29 | Buy |
200-day EMA: | 466.3 | Buy |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 58.17 | Buy |
20-day SMA: | 53.22 | Buy |
50-day SMA: | 51.3 | Buy |
200-day SMA: | 45.17 | Buy |
8-day EMA: | 60.15 | Buy |
20-day EMA: | 55.23 | Buy |
50-day EMA: | 51.77 | Buy |
200-day EMA: | 44.82 | Buy |
Mastercard Earnings Growth & MA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.77 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.33 per share, and an increase next year of $1.89 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.66 per share.
Mastercard Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Rhythm Pharmaceuticals Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |